These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 1462922)

  • 41. [Fetal supraventricular tachyarrhythmias refractory to initial therapy].
    Malvino E; Bruno MC; Gallo JP; Medrano JC; Ferrante D
    Medicina (B Aires); 2005; 65(2):138-42. PubMed ID: 16075808
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sotalol as first-line treatment for fetal tachycardia and neonatal follow-up.
    van der Heijden LB; Oudijk MA; Manten GT; ter Heide H; Pistorius L; Freund MW
    Ultrasound Obstet Gynecol; 2013 Sep; 42(3):285-93. PubMed ID: 23303470
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Treatment of resistant ventricular tachycardia with flecainide acetate. Flecainide Ventricular Tachycardia Study Group.
    Am J Cardiol; 1986 Jun; 57(15):1299-304. PubMed ID: 3717029
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Fetal tachyarrhythmias.
    Owen P; Cameron A
    Br J Hosp Med; 1997 Aug 20-Sep 2; 58(4):142-4. PubMed ID: 9373402
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficacy and safety of class IC antiarrhythmic agents for the treatment of coexisting supraventricular and ventricular tachycardia.
    Rinkenberger RL; Naccarelli GV; Berns E; Dougherty AH
    Am J Cardiol; 1988 Aug; 62(6):44D-55D. PubMed ID: 3136636
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Flecainide and anti-arrhythmia therapy].
    Croce L; Romano S; Pozzoni L; Lomuscio A
    Minerva Med; 1988 Mar; 79(3):229-34. PubMed ID: 3129677
    [TBL] [Abstract][Full Text] [Related]  

  • 47. First-Line Antiarrhythmic Transplacental Treatment for Fetal Tachyarrhythmia: A Systematic Review and Meta-Analysis.
    Alsaied T; Baskar S; Fares M; Alahdab F; Czosek RJ; Murad MH; Prokop LJ; Divanovic AA
    J Am Heart Assoc; 2017 Dec; 6(12):. PubMed ID: 29246961
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Flecainide in the intrauterine treatment of fetal supraventricular tachycardia.
    Krapp M; Baschat AA; Gembruch U; Geipel A; Germer U
    Ultrasound Obstet Gynecol; 2002 Feb; 19(2):158-64. PubMed ID: 11876808
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Flecainide for supraventricular tachyarrhythmias.
    Med Lett Drugs Ther; 1992 Jul; 34(875):71-2. PubMed ID: 1630411
    [No Abstract]   [Full Text] [Related]  

  • 50. Electrophysiological effects of flecainide on anisotropic conduction and reentry in infarcted canine hearts.
    Coromilas J; Saltman AE; Waldecker B; Dillon SM; Wit AL
    Circulation; 1995 Apr; 91(8):2245-63. PubMed ID: 7697855
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Oral flecainide for suppression of ventricular arrhythmias.
    Vanhaleweyk G; Balakumaran K; Lubsen J; Roelandt J; Hugenholtz PG
    Cardiology; 1984; 71(1):30-9. PubMed ID: 6722846
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Intravenous flecainide acetate for the clinical management of paroxysmal tachycardias.
    Nathan AW; Camm AJ; Bexton RS; Hellestrand KJ
    Clin Cardiol; 1987 May; 10(5):317-22. PubMed ID: 3109795
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The Safety and Effectiveness of Flecainide in Children in the Current Era.
    Cunningham T; Uzun O; Morris R; Franciosi S; Wong A; Jeremiasen I; Sherwin E; Sanatani S
    Pediatr Cardiol; 2017 Dec; 38(8):1633-1638. PubMed ID: 28840327
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Effective dose of flecainide for arrhythmia in children].
    Sumitomo N; Ushinohama H; Hara M; Otuka M; Harada K; Okuni M
    Kokyu To Junkan; 1993 Nov; 41(11):1079-82. PubMed ID: 8256048
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Flecainide acetate in the treatment of tachycardias associated with Mahaim fibres.
    Lau CP; Davies DW; Mehta D; Ward DW; Camm AJ
    Eur Heart J; 1987 Aug; 8(8):832-9. PubMed ID: 3117552
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical usefulness of flecainide acetate in the treatment of paroxysmal supraventricular arrhythmias.
    Camm AJ; Hellestrand KJ; Nathan AW; Bexton RS
    Drugs; 1985; 29 Suppl 4():7-13. PubMed ID: 4006783
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Neonatal ECG changes caused by supratherapeutic flecainide following treatment for fetal supraventricular tachycardia.
    Rasheed A; Simpson J; Rosenthal E
    Heart; 2003 Apr; 89(4):470. PubMed ID: 12639886
    [No Abstract]   [Full Text] [Related]  

  • 58. Pharmacologic management of supraventricular tachycardias in children. Part 1: Wolff-Parkinson-White and atrioventricular nodal reentry.
    Luedtke SA; Kuhn RJ; McCaffrey FM
    Ann Pharmacother; 1997 Oct; 31(10):1227-43. PubMed ID: 9337449
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficacy and safety of flecainide acetate in the maintenance of sinus rhythm after electrical cardioversion of chronic atrial fibrillation or atrial flutter.
    Van Gelder IC; Crijns HJ; Van Gilst WH; Van Wijk LM; Hamer HP; Lie KI
    Am J Cardiol; 1989 Dec; 64(19):1317-21. PubMed ID: 2511744
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Fetal supraventricular tachycardia with anasarca complicating benign extrasystole: treatment with flecainide. Apropos of a case].
    Hamel P; Febbraro W; Barjot P; Lindet Y; Muller G; Iselin M
    Arch Mal Coeur Vaiss; 1997 Mar; 90(3):407-10. PubMed ID: 9232080
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.